RACHEL PAULL: Open Payments
NPI 1689126617 · MURRELLS INLET, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 19 payments from 7 companies in 2025. Trend: 2023 $313 · 2024 $411 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $111 |
| Amgen Inc. | 4 | $91 |
| GENZYME CORPORATION | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Organon LLC | 2 | $42 |
| ABBVIE INC. | 1 | $29 |
| Almirall LLC | 1 | $22 |
Products named: TREMFYA, OTEZLA, DUPIXENT, RINVOQ, Rhapsido, Klisyri.
Industry payments across SC — which companies pay providers there.
